Records containing: Major Depressive Disorder
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2012-10-26Aripiprazole Augmentation of SSRI Antidepressant Therapy in Treatment Refractory Depression: Assessment of Symptom Reduction, Psychosocial Function, and Cognitive Function
-
CLINICAL_TRIALS study record update · 2012-10-26Time to Remission of Depressive Symptoms With Combined SSRI and Ramelteon
-
CLINICAL_TRIALS study record update · 2012-10-15A Randomized Controlled Trial of Cognitive Behavior Therapy Provided by Buddhist Monks vs. Treatment as Usual in the Treatment of Late Life-depression
-
CLINICAL_TRIALS study record update · 2012-10-08Brain Imaging of Psychotherapy for Depression (Includes, "Reward System Recovery Following Behavioral Activation Therapy in Depression")
-
CLINICAL_TRIALS study record update · 2012-09-27A Phase IIa, Multi-centre, Randomized, Double-Blind, Double-Dummy, Active and Placebo Controlled, Parallel Group Study to Assess the Effectiveness and Safety of AZD2066 After 6 Weeks of Treatment in Patients With Major Depressive Disorder - D0475C00020
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2012-09-21Toward Identifying the Mechanisms of Action in Mindfulness-Based Cognitive Therapy
-
CLINICAL_TRIALS study record update · 2012-09-12Randomized, Double Blind, Placebo Controlled, Single IV Dose Parallel Efficacy and Safety Study of GLYX-13 in Subjects With Inadequate/Partial Response to Antidepressants During the Current Episode of Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2012-09-11Incidence and Prevalence of and Factors Associated With Metabolic Syndrome and Thyroid Dysfunction in Patients With Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2012-09-11Phase IIa Study of Antidepression Use Natural Plants Extracted of Soline Capsule.
-
CLINICAL_TRIALS study record update · 2012-08-31Open Label, Observational, Non-interventional Study for the Evaluation of Remission Rates in Patients With MDD Under Treatment With Various Anti-depressives
-
CLINICAL_TRIALS study record update · 2012-08-17A Long-Term, Open-label Extension Study of F2695 SR in Adult Patients With Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2012-08-03N-methyl-D-aspartate Receptor (NMDAR)-Based Pharmacotherapy With D-cycloserine for Treatment-resistant Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2012-07-25A Phase IIb, Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Efficacy and Safety Study of Adjunctive AZD6765 in Subjects With Severe Major Depressive Disorder (MDD) and a History of Poor Response to Antidepressants
-
CLINICAL_TRIALS study record update · 2012-07-09A Double-Blind, Placebo-Controlled Study of Acamprosate Added to Escitalopram and Behavioral Treatment in Major Depressive Disorder (MDD) With Comorbid Alcohol Abuse/Dependence
-
CLINICAL_TRIALS study record update · 2012-07-09Duloxetine for Perimenopausal Depression
-
CLINICAL_TRIALS study record update · 2012-07-04A Phase I, Multiple-Dose, Randomized, Double-Blind, Oral Tyramine Pressor Response Study Comparing CX157 Tablets to Placebo in Healthy Male Volunteers
-
CLINICAL_TRIALS study record update · 2012-06-27A Randomized, Double-Blind, Placebo-Controlled Parallel-Group, Assessment of the Efficacy, Safety and Tolerability of CX157 (TriRima) 60mg Three Times a Day (TID) in Subjects With Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2012-06-27A Multicenter, Double-Blind, Placebo-Controlled, Randomized Withdrawal, Parallel Group Study To Evaluate The Efficacy And Safety Of 50 mg/Day Of DVS SR In Adult Outpatients With Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2012-06-25A Cross-sectional Observational Study to Describe Treatment Management of Patients With Major Depressive Disorder (MDD) and Inadequate Response to Antidepressants in Greece
-
CLINICAL_TRIALS study record update · 2012-05-25A Double-blind, Placebo-controlled Study Evaluating the Pharmacodynamic Effects of Two Fixed Doses of SSR149415 (250 mg Bid and 100 mg Bid) on Hypothalamic-pituitary-adrenal Axis Function in Outpatients With Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2012-05-23A Randomised, 6-week, Multicentre, Open-label, Rater-blinded Parallel Group Study Comparing Quetiapine Extended Release Monotherapy and Augmentation With Lithium Augmentation in Patients With Treatment Resistant Depression
-
CLINICAL_TRIALS study record update · 2012-05-09Fixed Dose Comparison of Escitalopram Combination in Adult Patients With Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2012-05-09Pioglitazone as an Adjunct for Moderate to Severe Depressive Disorder
-
CLINICAL_TRIALS study record update · 2012-05-09ClinicalTrials.gov study NCT00290914
-
CLINICAL_TRIALS study record update · 2012-05-04Department of AnesthesiologyJinling Hospital, Nanjing University School of Medicine, Nanjing, China